Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis

Critical Care Medicine

Volumn 28, Issue 2, 2000, Pages 433-437

  Riché, Florence C ^a   Cholley, Bernard P ^a   Panis, Yves H ^a   Laisné, Marie Josèphe C ^a   Briard, Claudette G ^a   Graulet, Anne Marie ^a   Guéris, Jean L ^a   Valleur, Patrice D ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Bacteremia; Cytokine; Infection; Interleukin 1; Interleukin 6; Peritonitis; Septic shock; Surgery; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTEREMIA; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONITIS; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0034047591     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200002000-00024     Document Type: Article

References (40)

1. 1. Bagby G, Plessala K, Wilson L, et al: Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis 1991; 163: 83-88
2. 2. Echtenacher B, Falk W, Männel D, et al: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145: 3762-3766
3. 3. Zanetti G, Neumann D, Gérain J, et al: Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J Immunol 1992; 148:1890-1897
4. 4. Cannon J, Tompkins R, Gelfand J, et al: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161:79-84
5. 5. Debets J, Kampmeijer R, van der Linden M, et al: Plasma tumor necrosis factor and mortality rate in critically ill septic patients. Crit Care Med 1989; 17:489-494
6. 6. Marks J, Berman-Marks C, Luce J, et al: Plasma tumor necrosis factor in patients with septic shock: mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 1990; 141:94-97
7. 7. Calandra T, Baumgartner J, Grau G, et al: Prognostic values of tumor necrosis factor/ cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 1990; 161:982-987
8. 8. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978
9. 9. Függer R, Zadrobilek E, Götzinger P, et al: Perioperative TNF and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection. Eur J Surg 1993; 159:525-529
10. 10. Patel R, Deen KI, Youngs J, et al: Interleukin-6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81:1306-1308
11. 11. Holzheimer R, Schein M, Wittmann D: Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg 1995; 130:1314-1319
12. 12. Riché F, Panis Y, Laisné M, et al: High tumor necrosis factor serum level is associated with abdominal septic shock: A prospective study in 59 patients. Surgery 1996; 120:801-7
13. 13. Hamilton G, Hofbauer S, Hamilton B: Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand J Infect Dis 1992; 24:361-368
14. 14. Rogy M, Oldenburg H, Coyle S, et al: Correlation between acute physiology and chronic health evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 1996; 83: 396-400
15. 15. Bone R, Balk R, Cerra F, et al: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus conference committee. Chest 1992; 101:1644-1661
16. 16. Legall J, Lemeshow S, Saulnier F: New simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
17. 17. Martich G, Danner R, Ceska M, et al: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 1991; 173:1021-1024
18. 18. Yoshimoto T, Nakanishi K, Hirose S, et al: High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-I/ tumor necrosis factor. J Immunol 1992; 148: 3596-3603
19. 19. Riché F, Dosquet C, Panis Y, et al: Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease. J Am Coll Surg 1995; 180: 718-724
20. 20. McMasters KM, Cheadle WG: Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent. J Surg Res 1993; 54:426-430
21. 21. Fieren M, Van den Bemd G, Bonta I, et al: Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumor necrosis factor during peritonitis. J Clin Lab Immunol 1991; 31:1-9
22. 22. Betjes M, Tuk C, Struijk D, et al: Interleukin 8 production by human peritoneal mesothelial cells in response to tumor necrosis factor alpha, and interleukin conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis 1993; 168: 1202-1210
23. 23. Holzheimer R, Muhrer K, L'Allemand N, et al: Intraabdominal infections: classification, mortality, scoring and physiopathology. Infection 1991; 19:447-452
24. 24. Zemel D, Koomen G, Hart A, et al: Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686-696
25. 25. Nieuwenhuijzen GA, Knapen MF, Hendriks T, et al: Elimination of various subpopulations of macrophages and the development of multiple-organ dysfunction syndrome in mice. Arch Surg 1997; 132:533-539
26. 26. Schein M, Wittmann D, Holzheimer R, et al: Hypothesis: compartimentalization of cytokines in intraabdominal infection. Surgery 1996; 119:694-700
27. 27. Gau-Jun T, Cheng-Deng K, Tzu-Chen Y, et al: Perioperative plasma concentrations of tumor necrosis factor alpha and interleukin-6 in infected patients. Crit Care Med 1996; 24:423-428
28. 28. Propst T, Propst A, Herold M, et al: Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid. Eur J Clin Invest 1993; 23:832-6
29. 29. Zeni F, Tardy B, Vindimian M, et al: High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993; 17:218-223
30. 30. Zemel D, Krediet R, Koomen G: Interleukin-8 during peritonitis in patients treated with CAPD: an in vivo model of acute inflammation. Nephrol Dial Transplant 1994; 9:169-174
31. 31. Bohnen J, Boulanger M, Meakins J, et al: Prognosis in generalized peritonitis: Relation to cause and risk factors. Arch Surg 1983; 118:285-290
32. 32. Dellinger E, Wertz M, Meakins J: Surgical infection stratification system for intra-abdominal infection. Arch Surg 1985; 120:21-29
33. 33. Bohnen J, Mustard R, Oxholm S, et al: APACHE II score and abdominal sepsis: a prospective study. Arch Surg 1988; 123: 225-229
34. 34. McLaughan G, Anderson I, Graut I, et al: Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg 1995; 82:524-529
35. 35. Onderdonk A, Bartlett J, Louie T, et al: Microbial synergy in polymicrobial surgical infections. Rev Infect Dis 1976; 7:151-170
36. 36. Burnett R, Haverstock D, Dellinger P, et al: Definition of the role of enterococcus in intrabdominal infection: analysis of a prospective randomized trial. Surgery 1995; 118: 717-721
37. 37. Dupont H, Montravers P, Mohler J, et al: Disparate findings on the role of virulence factors of enterococcus faecalis in mouse and rat models of peritonitis. Infect Immun 1998; 66:2570-2575
38. 38. Shapiro L, Gelfand J: Cytokines and sepsis: pathology and therapy. New Horiz 1993; 1:13-22
39. 39. Natanson C, Hoffman W, Suffredini A, et al: Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-783
40. 40. Whawell S, Scott-Commbes M, Vipond S, et al: Tumor necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells. Br J Surg 1994; 81:214-216